đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
The aim of this study is to evaluate the reactogenicity, safety and immunog...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-03-16
Trial ID
NCT00263666
Treatments Being Tested
To demonstrate that DTaP-IPV-HB-PRP\~T combined vaccine does not induce a h...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00313911
Treatments Being Tested
DTaP-HB-PRP\~T combined vaccine is being developed in order to comply with ...
Status
Completed
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT00514709
Treatments Being Tested
The purpose of this study is to support the registration of the pentavalent...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT00343889
Treatments Being Tested
This purpose of the study is to assess the safety and immunogenicity of a G...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-07-07
Trial ID
NCT01098474
Treatments Being Tested
To assess the immune memory following primary vaccination of DTPw-HBV/Hib v...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-02-10
Trial ID
NCT00169442
This is a study to show that vaccination with 1 dose of Tritanrix HB+Hib fo...
Status
Completed
Location
Research Institute for Tropical Medicine
Start Date
2011-05
Trial ID
NCT01357720
Treatments Being Tested
This is a study to compare the safety and immune response of a pentavalent ...
Status
Completed
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00348881
Treatments Being Tested
The present trial is a follow-up of AL203 study (NCT00343889). Primary Obj...
Status
Completed
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT00534833
Treatments Being Tested